Plastic and aesthetic nursing最新文献

Skin aging is caused by extrinsic and intrinsic factors and can lead to various aesthetic concerns and psychosocial stress. Exosome-based treatments have recently gained attention in the field of skin rejuvenation. This study aimed to retrospectively analyze the clinical efficacy of an exosome (CUREDOC EXOSOME REPAIR Advanced Solution Skin Booster, CUREDOC, Sejong, Korea) combined with microneedling treatment. We analyzed the medical records of 40 patients who received exosome skin booster (50 mcg/mL) and microneedling combination therapy at a single medical institution from January to March 2024. Physicians performed the treatment on each patient every 2 weeks for a total of 4 sessions. The physicians followed each patient for 8 weeks after the final treatment. The physicians evaluated each patient by taking clinical photographs, having each patient complete a satisfaction survey, assessing each patient using the Global Aesthetic Improvement Scale (GAIS), and documenting adverse events. The patient group had a mean age of 41.2 ± 6.3 years. The results of the study showed a high patient acceptance rate, with an overall satisfaction of 87.5%, an 82% intention to undergo repeat treatment, and an 85% willingness to recommend the treatment. According to the GAIS assessments, 85% of patients scored "improved" or greater. Adverse events were transient and mild, and there were no serious adverse reactions reported. Based on the results of this study, the combination of exosome skin booster and microneedling treatment can be considered a safe and effective option for improving facial aging.

In this cross-sectional study, we evaluated the relationship between health literacy and acceptance of cosmetic surgery using the Turkish Health Literacy Scale-32 and the Acceptance of Cosmetic Surgery Scale. The mean age of the 379 patients included in the study was 31.19 ± 7.02 years. A total of 61.7% (n = 234) of the participants had a history of cosmetic surgery. The most common aesthetic surgery was performed on the face, and the most preferred type of surgical intervention was rhinoplasty. Patients stated that they primarily obtained information about plastic surgery from social media and the internet. We found a strong statistically significant positive correlation between the two scales (r = 0.757; p < .001). We found statistically significantly different scale scores based on the patients' education (p < .001) and income levels (p < .05). Patients with a history of plastic surgery had statistically significant higher acceptance levels (p = .003). There is a need for education and counseling services to increase the health literacy of plastic surgery patients and support them in making informed decisions.

In a single-center study conducted over a 12-month study period, we investigated the long-term safety and efficacy of Profilo Body® (IBSA Farmaceutici Italia Srl, Lodi, Italy) for treating upper inner arm skin laxity. The study participants included women (37-65 years) with at least initial signs of skin laxity and roughness on their upper arms. The treatment consisted of two injections of Profhilo Body® one month apart, followed by five injections two months apart, and a follow-up evaluation one month later. We assessed the study participants using the IBSA Photographic Scale for Assessment of Upper Inner Arm Skin Laxity. At the end of the study, the participants also completed a self-evaluation questionnaire related to product efficacy and tolerability. A total of 34 enrolled participants received the first three injections. A total of 32 participants received the next four injections. We found that slight ecchymosis occurred in 36 participants. The results of the study showed a significant decrease in median IBSA Photographic Scale for Assessment of Upper Inner Arm Skin Laxity scores at Month 3 compared with baseline scores (p < .0001). This decrease was maintained through Month 12. At least 50% of the participants experienced a moderate improvement in skin firmness, smoothness, brightness, hydration, and overall inner arm appearance that continued through Month 12. The participants self-evaluated tolerability of the product as "optimal." Based on the results of this study, we conclude that long-term use of Profhilo® Body is safe and effective for reducing skin laxity of the upper inner arms.

This review explores the efficacy and safety of using needles compared with cannulas for administering dermal fillers. We assessed and compared needles and cannulas based on the accuracy of injection, amount of associated tissue damage, procedural duration, vascular complications, and injection techniques and also highlighted their respective advantages and limitations. Needles facilitate rapid, precise injections and are suitable for shallow, targeted applications; however, because of their sharp points, if not handled with exacting techniques, needles pose a higher risk for misplacement, vascular damage, and tissue trauma. Conversely, because of their blunt tips, cannulas significantly reduce the potential for perforating blood vessels and thus provide a safer alternative for use in areas with a dense vascular network such as the forehead and nasolabial folds. Although requiring a longer procedure time and the creation of an entry point, using cannulas minimizes tissue disruption and is less likely to cause severe vascular complications. This research highlights the importance of choosing the appropriate injection tool based on specific treatment areas, desired outcomes, and inherent risks. Implementing an informed approach when using needles and cannulas can enhance both patient safety and aesthetic results in facial enhancements.